Leap Therapeutics has transitioned into a ZEC treasury company, acquiring around 203,000 tokens at an average price of $245 each. This strategic shift indicates the company’s focus on enhancing its asset portfolio. By acquiring these tokens, Leap Therapeutics positions itself to leverage the potential growth within the cryptocurrency space. The company’s decision to become a treasury firm reflects an evolving trend among businesses seeking to diversify their investments.
This update was auto-syndicated to Bpaynews from real-time sources. It was normalized for clarity, SEO and Google News compatibility.
